Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy

BMC Nephrol. 2021 Sep 25;22(1):319. doi: 10.1186/s12882-021-02510-y.

Abstract

Background: Progression of renal anemia has been shown to be associated with advanced renal tubulointerstitial lesions. This retrospective study investigated the impact of lower hemoglobin (Hb) levels and renal interstitial fibrosis and tubular atrophy (IFTA) on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy.

Methods: A total of 233 patients were enrolled. The severity of IFTA was scored according to the classification by the Renal Pathology Society. Patients were stratified according to baseline Hb tertiles by IFTA status. The outcomes were the first occurrence of renal events (requirement for dialysis or 50 % decline in estimated glomerular filtration rate from baseline) and all-cause mortality.

Results: At baseline, 151 patients had severe IFTA. There were no patients who have been received erythropoiesis-stimulating agents at the time of renal biopsy. The severity of IFTA was the independent pathological factor of lower Hb levels. During the mean follow-up period of 8.6 years (maximum, 32.4 years), 119 renal events and 42 deaths were observed. Compared with the combined influence of the highest tertile of Hb and mild IFTA, the risks of renal events were higher for the middle tertile and for the lowest tertile of Hb in severe IFTA, whereas the risk of renal events was higher for the lowest tertile of Hb in mild IFTA. The risk of mortality was higher for the lowest tertile of Hb only in severe IFTA. There were significant interactions of tertile of Hb and IFTA in renal events and mortality.

Conclusions: Impacts of lower Hb levels on long-term outcomes of diabetic nephropathy were greater in severe IFTA than in mild IFTA.

Keywords: Diabetic kidney disease; Diabetic nephropathy; Hemoglobin; Interstitial fibrosis and tubular atrophy; Mortality; Renal events.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopsy
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / pathology
  • Diabetic Nephropathies / blood*
  • Diabetic Nephropathies / mortality
  • Diabetic Nephropathies / pathology
  • Female
  • Fibrosis
  • Hemoglobins / analysis*
  • Humans
  • Kidney / pathology*
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Risk Factors

Substances

  • Hemoglobins